Core Viewpoint - Aardvark Therapeutics, Inc. (AARD) shows significant upside potential with a mean price target of 11.13 [1] Price Targets and Analyst Consensus - The average price targets from analysts range from a low of 50, with a standard deviation of $13.05, suggesting variability in estimates [2] - The lowest estimate indicates a potential increase of 79.7%, while the highest suggests a 349.2% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about AARD's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 4.7%, with two estimates moving higher and no negative revisions [12] - AARD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]
Wall Street Analysts Think Aardvark Therapeutics, Inc. (AARD) Could Surge 180.77%: Read This Before Placing a Bet